Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study

Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study

Abstract Background Patients with coronary chronic total occlusion (CTO) require effective antiplatelet therapy after percutaneous coronary intervention (PCI). Ticagrelor has more pronounced platelet inhibition than clopidogrel. However, the most appropriate dose of ticagrelor in East Asian populati...

Full description

Bibliographic Details
Main Authors: Yong Wang, Hong-wei Zhao, Cheng-fu Wang, Xiao-jiao Zhang, Jie Tao, Chun-sheng Cui, Qing-kun Meng, Yu Zhu, De-feng Luo, Ai-jie Hou, Bo Luan
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Cardiovascular Disorders
Subjects:
Ticagrelor
Clopidogrel
Chronic total occlusion
Percutaneous coronary intervention
Online Access:http://link.springer.com/article/10.1186/s12872-019-01307-0

Internet

http://link.springer.com/article/10.1186/s12872-019-01307-0

Similar Items